Inpatient management of iron deficiency anemia in pediatric patients with inflammatory bowel disease: A single center experience

Table 1 Subject characteristics (n = 92)

	Overall (n = 92)	Iron therapy			P value
		No iron (n = 18)	Oral iron (n = 17)	IV iron (n = 57)
Age (years), median (IQR)	15 (11–18)	13 (10–18)	15 (13–17)	15 (11–18)	0.70
Female sex, n (%)	41 (45)	10 (56)	7 (41)	24 (42)	0.63
IBD diagnosis, n (%)					0.008
CD	47 (51)	16 (89)	4 (24)	27 (47)
UC	41 (45)	2 (11)	11 (65)	28 (49)
IC	4 (4)	0 (0)	2 (12)	2 (4)
Disease duration (months), median (IQR)	1.4 (0.1–31.2)	19.6 (0.1–82.3)	1.0 (0.2–16.6)	1.5 (0.1-24.6)	0.58
CD phenotype, n (%)					0.41
Inflammatory	28 (60)	9 (56)	1 (25)	18 (67)
Fistula	10 (21)	4 (25)	2 (50)	4 (15)
Stricture	9 (19)	3 (19)	1 (25)	5 (19)
UC phenotype, n (%)					0.76
Pancolitis	34 (83)	2 (100)	10 (91)	22 (79)
Left-sided colitis	7 (17)	0 (0)	1 (9)	6 (21)

IQR: Interquartile range; IBD: Inflammatory bowel disease; IV: Intravenous; UC: Ulcerative colitis; CD: Crohn’s disease; IC: Indeterminate colitis.